SuperworthPulmonx market cap LUNG
Share price times shares outstanding: what the whole company sells for, since 2020.
- Today, Oct 23, 2026
- $78.6M
- Highest close in our data
- $2.5B
- Dec 2020
Pulmonx is worth $78.6M at the close on Oct 23, 2026, at $1.83 a share.
That is up 18% over the last year and down 94% over five years.
Its highest close in our data was $2.5B in Dec 2020.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $78.6M | $49.4M | $103.9M | −14% |
| 2025 | $91.6M | $59.4M | $353.8M | −65% |
| 2024 | $264.6M | $218.9M | $548.6M | −46% |
| 2023 | $488.4M | $291.4M | $508.8M | +55% |
| 2022 | $315.4M | $179.6M | $1.1B | −73% |
| 2021 | $1.2B | $1.1B | $2.3B | −52% |
| 2020 | $2.5B | $1.7B | $2.5B | n/a |
Against its peers
Companies in Medical - Instruments & Supplies nearest Pulmonx's size, closest first, today.
| Company | Market cap |
|---|---|
| LUNGPulmonx | $78.6M |
| KEQUKewaunee Scientific | $94.9M |
| APTAlpha Pro Tech | $56.7M |
| NEPHNephros | $38.3M |
| PDEXPro DEX | $199.3M |
| UTMDUtah Medical Products | $236.3M |
| INFUInfuSystem | $277.6M |
| EMBCEmbecta | $380.2M |
| TCMDTactile Systems Technology | $535.5M |
| MDXGMimedx | $569.9M |
| MOVMovado | $701.9M |
| Peer median | $257M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Pulmonx
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.